Consequences of Pharmaceutical Fraud Settlements: Off-Label Marketing Continues?
Reporter Susan Todd wrote a fine article in the June 6, 2010 Star –Ledger about off-label marketing. “There are very few companies that haven’t had…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: off label
GI Drug Overhyped, Warns FDA
On May 5th, the FDA posted a letter sent to Shire Development, Inc. regarding the marketing of LIALDA, an oral sustained release multimatrix formulation of…
Read More »Biotech Company and Its Top Management Indicted for Illegal Promotion, Making False Statements to the FDA
The Federal Bureau of Investigation (FBI) Boston announced October 28, 2009, that Stryker Biotech and its top management had been indicted for illegal promotion of…
Read More »Grassley Probes into Ghostwriting Practices that May Result in Pharmaceutical Fraud
United States Senator Charles E. Grassley of Iowa has asked eight leading medical journals to describe their ghostwriting policies and practices. The inquiry is part…
Read More »Off Label Marketing Costs Jazz Pharmaceuticals $20 Million
Jazz Pharmaceuticals, Inc. (”Jazz”) has agreed to pay $20 million in order to resolve both criminal and civil investigations which were conducted by the United…
Read More »Purdue Pharma Agrees to $19.5 Million Settlement Over Off Label Marketing of OxyContin
Purdue Pharma has agreed to settle claims by 26 states and the District of Columbia for marketing and promoting OxyContin for unapproved uses i.e. for…
Read More »499 Million Bristol-Myers Squibb Agreement to Settle Fraud Charges
The United States Department of Justice has reached a tentative settlement with Bristol-Myers Squibb in the amount of $499 million to settle several investigations involving…
Read More »Pharma Has Its Nose In Clinical Trials
A survey published in the New York Journal of Medicine found that more than a third of experts who oversee clinical trials at both medical…
Read More »Omnicare Really Did Not Care….A Cool $49.5 Million Settles Omnicare Drug Provider Case
Omnicare has agreed to pay $49.5 million to settle Medicaid fraud claims. Omnicare, one of the country’s leading suppliers of pharmacy services to nursing homes,…
Read More »